These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Lebrin F; Srun S; Raymond K; Martin S; van den Brink S; Freitas C; Bréant C; Mathivet T; Larrivée B; Thomas JL; Arthur HM; Westermann CJ; Disch F; Mager JJ; Snijder RJ; Eichmann A; Mummery CL Nat Med; 2010 Apr; 16(4):420-8. PubMed ID: 20364125 [TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life. Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465 [TBL] [Abstract][Full Text] [Related]
6. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia]. Peng HL; Hu GY; Zhang GS; Gong FJ Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide. Lacout A; Marcy PY; El Hajjam M; Lacombe P Med Hypotheses; 2013 May; 80(5):587-8. PubMed ID: 23452644 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and treatment of hereditary hemorrhagic telangiectasia. Li S; Wang SJ; Zhao YQ Medicine (Baltimore); 2018 Aug; 97(31):e11687. PubMed ID: 30075565 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. Sadick H; Naim R; Gössler U; Hörmann K; Riedel F Int J Mol Med; 2005 Jan; 15(1):15-9. PubMed ID: 15583822 [TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis. Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172 [TBL] [Abstract][Full Text] [Related]
12. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia]. Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875 [TBL] [Abstract][Full Text] [Related]
13. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia. Penaloza A; Vekemans MC; Lambert C; Hermans C Blood Coagul Fibrinolysis; 2011 Oct; 22(7):616-8. PubMed ID: 21885956 [TBL] [Abstract][Full Text] [Related]
14. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064 [TBL] [Abstract][Full Text] [Related]
16. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia. Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Cirulli A; Liso A; D'Ovidio F; Mestice A; Pasculli G; Gallitelli M; Rizzi R; Specchia G; Sabbà C Acta Haematol; 2003; 110(1):29-32. PubMed ID: 12975554 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. Wang XY; Chen Y; Du Q Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527 [TBL] [Abstract][Full Text] [Related]
19. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review. Harrison L; Kundra A; Jervis P J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780 [TBL] [Abstract][Full Text] [Related]
20. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia. Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]